12 Works
Additional file 1 of Doppler study of portal vein and renal venous velocity predict the appropriate fluid response to diuretic in ICU: a prospective observational echocardiographic evaluation
Pierre-Grégoire Guinot, Pierre-Alain Bahr, Stefan Andrei, Bogdan A. Popescu, Vincenza Caruso, Paul-Michel Mertes, Vivien Berthoud, Maxime Nguyen & Belaid Bouhemad
Additional file 1: Table S1. Hemodynamic and echocardiographic measurements according to congestive response to diuretic treatment (Appropriate fluid depletion vs Control). $p < 0.05 comparison between two groups of patient. *p < 0.05 comparison with baseline.
Risk and protective factors for the possible development of post-traumatic stress disorder among intensive care professionals in France during the first peak of the COVID-19 epidemic
Alexandra Laurent, Alicia Fournier, Florent Lheureux, Anne-Laure Poujol, Victoire Deltour, Fiona Ecarnot, Nicolas Meunier-Beillard, Mélanie Loiseau, Christine Binquet & Jean-Pierre Quenot
Intensive care units (ICU) are among the healthcare services most affected by the COVID-19 crisis. Stressors related to insecurity, unpredictability, patient death and family distress are significant, and put healthcare workers (HCWs) at high risk of post-traumatic stress disorder (PTSD). The aims of this study were to measure the prevalence of post-traumatic stress disorder in HCWs and to identify risk factors and protective factors during the epidemic in France. During the first peak of the...
Additional file 1 of Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
Diana-Alexandra Ertl, Justin Le Lorier, Andreas Gleiss, Séverine Trabado, Candace Bensignor, Christelle Audrain, Volha Zhukouskaya, Régis Coutant, Jugurtha Berkenou, Anya Rothenbuhler, Gabriele Haeusler & Agnès Linglart
Additional file 1: Table S1. Demographic, clinical and biochemical characteristics for group 1 (burosumab only). Median, minimum and maximum for demographic and biochemical parameters.
Additional file 2 of Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
Diana-Alexandra Ertl, Justin Le Lorier, Andreas Gleiss, Séverine Trabado, Candace Bensignor, Christelle Audrain, Volha Zhukouskaya, Régis Coutant, Jugurtha Berkenou, Anya Rothenbuhler, Gabriele Haeusler & Agnès Linglart
Additional file 2: Table S2 Demographic, clinical and biochemical characteristics for group 2 (burosumab and rhGH). Median, minimum and maximum for demographic and biochemical parameters
Additional file 1 of Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
Matthieu Raymond, Aurélie Le Thuaut, Pierre Asfar, Cédric Darreau, Florian Reizine, Gwenhaël Colin, Charly Dano, Julien Lorber, Baptiste Hourmant, Agathe Delbove, Aurélien Frérou, Jean Morin, Pierre Yves Egreteau, Philippe Seguin, Jean Reignier, Jean-Baptiste Lascarrou & Emmanuel Canet
Additional file 1: Appendix S1. List of the 13 participating intensive care units in France. Appendix S2. Supplementary Methods. Table S1. Multivariable analysis to identify factors associated with day-28 mortality. Table S2. Univariate analysis to identify factors associated with day-28 mortality among the 3 groups of patients (Early steroids, late steroids, and no steroids). e-Table S3. Multivariable analysis to identify factors associated with day-28 mortality among the 3 groups of patients (Early steroids, late steroids,...
Additional file 2 of Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
Diana-Alexandra Ertl, Justin Le Lorier, Andreas Gleiss, Séverine Trabado, Candace Bensignor, Christelle Audrain, Volha Zhukouskaya, Régis Coutant, Jugurtha Berkenou, Anya Rothenbuhler, Gabriele Haeusler & Agnès Linglart
Additional file 2: Table S2 Demographic, clinical and biochemical characteristics for group 2 (burosumab and rhGH). Median, minimum and maximum for demographic and biochemical parameters
Risk and protective factors for the possible development of post-traumatic stress disorder among intensive care professionals in France during the first peak of the COVID-19 epidemic
Alexandra Laurent, Alicia Fournier, Florent Lheureux, Anne-Laure Poujol, Victoire Deltour, Fiona Ecarnot, Nicolas Meunier-Beillard, Mélanie Loiseau, Christine Binquet & Jean-Pierre Quenot
Intensive care units (ICU) are among the healthcare services most affected by the COVID-19 crisis. Stressors related to insecurity, unpredictability, patient death and family distress are significant, and put healthcare workers (HCWs) at high risk of post-traumatic stress disorder (PTSD). The aims of this study were to measure the prevalence of post-traumatic stress disorder in HCWs and to identify risk factors and protective factors during the epidemic in France. During the first peak of the...
Additional file 1 of Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
Matthieu Raymond, Aurélie Le Thuaut, Pierre Asfar, Cédric Darreau, Florian Reizine, Gwenhaël Colin, Charly Dano, Julien Lorber, Baptiste Hourmant, Agathe Delbove, Aurélien Frérou, Jean Morin, Pierre Yves Egreteau, Philippe Seguin, Jean Reignier, Jean-Baptiste Lascarrou & Emmanuel Canet
Additional file 1: Appendix S1. List of the 13 participating intensive care units in France. Appendix S2. Supplementary Methods. Table S1. Multivariable analysis to identify factors associated with day-28 mortality. Table S2. Univariate analysis to identify factors associated with day-28 mortality among the 3 groups of patients (Early steroids, late steroids, and no steroids). e-Table S3. Multivariable analysis to identify factors associated with day-28 mortality among the 3 groups of patients (Early steroids, late steroids,...
Additional file 1 of Doppler study of portal vein and renal venous velocity predict the appropriate fluid response to diuretic in ICU: a prospective observational echocardiographic evaluation
Pierre-Grégoire Guinot, Pierre-Alain Bahr, Stefan Andrei, Bogdan A. Popescu, Vincenza Caruso, Paul-Michel Mertes, Vivien Berthoud, Maxime Nguyen & Belaid Bouhemad
Additional file 1: Table S1. Hemodynamic and echocardiographic measurements according to congestive response to diuretic treatment (Appropriate fluid depletion vs Control). $p < 0.05 comparison between two groups of patient. *p < 0.05 comparison with baseline.
Additional file 1 of Outcomes of mild-to-moderate postresuscitation shock after non-shockable cardiac arrest and association with temperature management: a post hoc analysis of HYPERION trial data
Ines Ziriat, Aurélie Le Thuaut, Gwenhael Colin, Hamid Merdji, Guillaume Grillet, Patrick Girardie, Bertrand Souweine, Pierre-François Dequin, Thierry Boulain, Jean-Pierre Frat, Pierre Asfar, Bruno Francois, Mickael Landais, Gaëtan Plantefeve, Jean-Pierre Quenot, Jean-Charles Chakarian, Michel Sirodot, Stéphane Legriel, Nicolas Massart, Didier Thevenin, Arnaud Desachy, Arnaud Delahaye, Vlad Botoc, Sylvie Vimeux, Frederic Martino … & Jean Baptiste Lascarrou
Additional file 1: Fig. S1. Study flowchart. Table S1. Baseline characteristics and mortality in the groups with vs. without mild-to-moderate postresuscitation shock (PRS) at intensive-care-unit (ICU) admission. Table S2. Multivariate logistic regression modelling to identify admission variables associated with a favourable outcome on day 90 in the overall population (n = 532).
Additional file 1 of Outcomes of mild-to-moderate postresuscitation shock after non-shockable cardiac arrest and association with temperature management: a post hoc analysis of HYPERION trial data
Ines Ziriat, Aurélie Le Thuaut, Gwenhael Colin, Hamid Merdji, Guillaume Grillet, Patrick Girardie, Bertrand Souweine, Pierre-François Dequin, Thierry Boulain, Jean-Pierre Frat, Pierre Asfar, Bruno Francois, Mickael Landais, Gaëtan Plantefeve, Jean-Pierre Quenot, Jean-Charles Chakarian, Michel Sirodot, Stéphane Legriel, Nicolas Massart, Didier Thevenin, Arnaud Desachy, Arnaud Delahaye, Vlad Botoc, Sylvie Vimeux, Frederic Martino … & Jean Baptiste Lascarrou
Additional file 1: Fig. S1. Study flowchart. Table S1. Baseline characteristics and mortality in the groups with vs. without mild-to-moderate postresuscitation shock (PRS) at intensive-care-unit (ICU) admission. Table S2. Multivariate logistic regression modelling to identify admission variables associated with a favourable outcome on day 90 in the overall population (n = 532).
Additional file 1 of Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
Diana-Alexandra Ertl, Justin Le Lorier, Andreas Gleiss, Séverine Trabado, Candace Bensignor, Christelle Audrain, Volha Zhukouskaya, Régis Coutant, Jugurtha Berkenou, Anya Rothenbuhler, Gabriele Haeusler & Agnès Linglart
Additional file 1: Table S1. Demographic, clinical and biochemical characteristics for group 1 (burosumab only). Median, minimum and maximum for demographic and biochemical parameters.
Affiliations
-
Centre Hospitalier Universitaire Dijon Bourgogne12
-
Centre Hospitalier Universitaire d'Angers8
-
Inserm8
-
University of Burgundy6
-
University of Paris6
-
University of Strasbourg4
-
University of Angers4
-
Centre Hospitalier Universitaire de Nantes4
-
Assistance Publique - Hôpitaux de Paris3
-
University of Paris-Saclay3